{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T04:56:56Z","timestamp":1792299416563,"version":"4.4.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,2,5]],"date-time":"2014-02-05T00:00:00Z","timestamp":1391558400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1007\/s10067-014-2512-7","type":"journal-article","created":{"date-parts":[[2014,2,4]],"date-time":"2014-02-04T01:42:58Z","timestamp":1391478178000},"page":"603-608","source":"Crossref","is-referenced-by-count":24,"title":["Inflammatory myopathy with anti-SRP antibodies: case series of a South Australian cohort"],"prefix":"10.1007","volume":"34","author":[{"given":"Sajini K","family":"Basnayake","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Blumbergs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju Ann","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J","family":"Roberts-Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidya","family":"Limaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,2,5]]},"reference":[{"key":"2512_CR1","doi-asserted-by":"crossref","first-page":"R39","DOI":"10.1186\/ar1895","volume":"8","author":"R Karin","year":"2006","unstructured":"Karin R, Frederick Miller W, Bernhard D, Stephen H (2006) Human autoantibodies against the 54 kDa protein of the signal recognition particle block function at multiple stages. Arthritis Res Ther 8:R39","journal-title":"Arthritis Res Ther"},{"key":"2512_CR2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/art.11484","volume":"50","author":"AH Kao","year":"2004","unstructured":"Kao AH, Lacomis D, Lucas M, Fertig N, Oddis CV (2004) Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy. Arthritis Rheum 50:209\u2013215","journal-title":"Arthritis Rheum"},{"key":"2512_CR3","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/ard.60.2.116","volume":"60","author":"R Brouwer","year":"2001","unstructured":"Brouwer R, Hengstman GJ, Vree Egberts W, Ehrfeld H, Bozic B, Ghirardello A et al (2001) Autoantibody profiles in the sera of European patients with myositis. Ann Rheum Dis 60:116\u2013123","journal-title":"Ann Rheum Dis"},{"key":"2512_CR4","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/art.1780330908","volume":"33","author":"IN Targoff","year":"1990","unstructured":"Targoff IN, Johnson AE, Miller FW (1990) Antibody to signal recognition particle in polymyositis. Arthritis Rheum 33:1361\u20131370","journal-title":"Arthritis Rheum"},{"key":"2512_CR5","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/jnnp.73.4.420","volume":"73","author":"T Miller","year":"2002","unstructured":"Miller T, Al-Lozi MT, Lopate G, Pestronk A (2002) Myopathy with antibodies to the signal recognition particle: clinical and pathological features. J Neurol Neurosurg Psychiatry 73:420\u2013428","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2512_CR6","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/art.1780330908","volume":"33","author":"N Ira","year":"1990","unstructured":"Ira N, Targoff, Arthur Johnson E, Frederick Miller W (1990) Antibody to signal recognition particle in polymyositis. Arthritis Rheum 33:1361\u20131370","journal-title":"Arthritis Rheum"},{"key":"2512_CR7","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1136\/ard.2006.052191","volume":"65","author":"GJ Hengstman","year":"2006","unstructured":"Hengstman GJ, Ter Laak HJ, Vree Egberts WT, Lundberg IE, Moutsopoulos HM, Vencovsky J et al (2006) Anti-SRP autoantibodies, marker of a necrotizing myopathy. Ann Rheum Dis 65:1635\u20131638","journal-title":"Ann Rheum Dis"},{"key":"2512_CR8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/PL00007850","volume":"249","author":"GJ Hengstman","year":"2002","unstructured":"Hengstman GJ, Brouwer R, Egberts WT, Seelig HP, Jongen PJ, van Venrooij WJ (2002) Clinical and serological characteristics of 125 Dutch myositis patients: myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies. J Neurol 249:69\u201375","journal-title":"J Neurol"},{"key":"2512_CR9","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00005792-199111000-00002","volume":"70","author":"LA Love","year":"1991","unstructured":"Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas M, Plotz PH, Miller FW (1991) A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous groups. Medicine 70:360\u2013374","journal-title":"Medicine"},{"key":"2512_CR10","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/1529-0131(199707)40:7<1257::AID-ART10>3.0.CO;2-R","volume":"40","author":"I Hausmanowa-Petrusewicz","year":"1997","unstructured":"Hausmanowa-Petrusewicz I, Kowalska-Oledzka E, Miller FW, Jarzabek CM, Targoff IN, Blaszczyk KM et al (1997) Clinical, serologic, and immunogenetic features in Polish patients with idiopathic inflammatory myopathy. Arthritis Rheum 40:1257\u20131266","journal-title":"Arthritis Rheum"},{"key":"2512_CR11","doi-asserted-by":"crossref","unstructured":"Benveniste O, Drouot L, Jouen F, Charuel JL, Bloch-Queyrat C, Behin A, Amoura Z, Marie I, Guiguet M, Eymard B, Gilbert D, Tron F, Herson S, Musset L, Boyer O (2011) Anti-signal recognition particle auto-antibody levels correlate with creatine kinase activity in patients with necrotizing myopathy. Arthritis Rheum","DOI":"10.1002\/art.30344"},{"issue":"9","key":"2512_CR12","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1002\/acr.20219","volume":"62","author":"R Valiyil","year":"2010","unstructured":"Valiyil R, Casciola-Rosen L, Hong G, Mammen A, Christopher-Stine L (2010) Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case series. Arthritis Care Res 62(9):1328\u20131334","journal-title":"Arthritis Care Res"},{"key":"2512_CR13","first-page":"887","volume":"26","author":"SM Sultan","year":"2008","unstructured":"Sultan SM, Ng KP, Edwards JC, Isenberg DA, Cambridge G (2008) Clinical outcome following B cell depletion therapy in eight patients with refractory inflammatory myopathy. Clin Exp Rheumatol 26:887\u2013893","journal-title":"Clin Exp Rheumatol"},{"key":"2512_CR14","first-page":"221","volume-title":"Structural and molecular basis of skeletal muscle disease","author":"R Hohlfeld","year":"2002","unstructured":"Hohlfeld R (2002) Polymyositis and dermatomyositis. In: Karpati G (ed) Structural and molecular basis of skeletal muscle disease. ISN Neuropath Press, Switzerland, pp 221\u2013227"},{"key":"2512_CR15","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1016\/j.lpm.2011.01.005","volume":"40","author":"MC Dalakas","year":"2011","unstructured":"Dalakas MC (2011) Pathophysiology of inflammatory and autoimmune myopathies. Press Med 40:e237\u2013e247","journal-title":"Press Med"},{"key":"2512_CR16","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1212\/01.wnl.0000277527.69388.fe","volume":"70","author":"N Chahin","year":"2008","unstructured":"Chahin N, Engel AG (2008) Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM. Neurology 70:418\u2013424","journal-title":"Neurology"},{"key":"2512_CR17","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0889-857X(02)00021-2","volume":"28","author":"FL Mastalgia","year":"2002","unstructured":"Mastalgia FL, Philips VA (2002) Idiopathic inflammatory myopathies, epidemiology, classification and diagnostic criteria. Rheum Dis Clin North Am 28:723\u2013741","journal-title":"Rheum Dis Clin North Am"},{"issue":"10","key":"2512_CR18","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/rheumatology\/ken325","volume":"47","author":"S Suzuki","year":"2008","unstructured":"Suzuki S, Satoh T, Sato S, Otomo M, Hirayama Y, Sato H, Kawai M, Ishihara T, Suzuki N, Kuwana M (2008) Clinical utility of anti-signal recognition particle antibody in the differential diagnosis of myopathies. Rheumatology (Oxford) 47(10):1539\u20131542","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"2512_CR19","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1002\/art.30344","volume":"63","author":"O Benveniste","year":"2011","unstructured":"Benveniste O, Drouot L, Jouen F, Charuel JL, Bloch-Queyrat C, Behin A, Amoura Z, Marie I, Guiguet M, Eymard B, Gilbert D, Tron F, Herson S, Musset L, Boyer O (2011) Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy. Arthritis Rheum 63(7):1961\u20131971","journal-title":"Arthritis Rheum"},{"issue":"1","key":"2512_CR20","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.autrev.2009.03.005","volume":"9","author":"J R\u00f6nnelid","year":"2009","unstructured":"R\u00f6nnelid J, Barbasso Helmers S, Storfors H, Grip K, R\u00f6nnblom L, Franck-Larsson K, Nordmark G, Lundberg IE (2009) Use of a commercial line blot assay as a screening test for autoantibodies in inflammatory myopathies. Autoimmun Rev 9(1):58\u201361","journal-title":"Autoimmun Rev"},{"key":"2512_CR21","volume-title":"Serological testing in myositis patients: diagnostic accuracy of a commercial line blot assay. 6","author":"A Ghirardello","year":"2008","unstructured":"Ghirardello A, Rampudda ME, Bassi N, Zampieri S, Grypiotis P, Bendo R, Arienti S, Tonon G, Lundberg IE, Doria A (2008) Serological testing in myositis patients: diagnostic accuracy of a commercial line blot assay. 6. International Congress on Autoimmunity, Porto"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-014-2512-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-014-2512-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-014-2512-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T04:40:28Z","timestamp":1565152828000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-014-2512-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,5]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["2512"],"URL":"https:\/\/doi.org\/10.1007\/s10067-014-2512-7","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,5]]}}}